ALK-Abelló A/S
ALK-B
Rang in aandelen
#2406
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Aandeelprijs
$36.15
Marktkapitalisatie
$8.02B
Verandering (1 dag)
-0.74%
Verandering (1 jaar)
8.74%
Land
DK
Handel ALK-Abelló A/S (ALK-B)
Categorie
Healthcare
Koersgeschiedenis voor ALK-Abelló A/S (ALK-B)
Hoogste slotkoers: $35.32 op 2026-10-01
Laagste slotkoers: $2.20 op 2000-03-01
Laagste slotkoers: $2.20 op 2000-03-01
Koersgeschiedenis van ALK-Abelló A/S van 2000 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 0.06% |
| 2025 | 59.11% |
| 2024 | 58.09% |
| 2023 | 1.18% |
| 2022 | -44.26% |
| 2021 | 35.05% |
| 2020 | 52.05% |
| 2019 | 69.02% |
| 2018 | 21.48% |
| 2017 | -6.26% |
| 2016 | 1.94% |
| 2015 | 12.10% |
| 2014 | 0.42% |
| 2013 | 62.90% |
| 2012 | 20.99% |
| 2011 | -3.28% |
| 2010 | -29.09% |
| 2009 | -18.50% |
| 2008 | -23.13% |
| 2007 | -41.96% |
| 2006 | 116.04% |
| 2005 | -9.24% |
| 2004 | 116.11% |
| 2003 | 47.42% |
| 2002 | 45.17% |
| 2001 | -23.57% |
| 2000 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $532.09 | 24.77% |
US
|
|
| $236.63 | 781.30% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $889.94 | 9.31% |
NL
|
|
| $291.42 | 2.39% |
BE
|
